Patient Acquisition Cost: How to Calculate It and What's Driving Yours Up

Ask five health founders for their patient acquisition cost and you’ll get five numbers calculated five different ways. One counts ad spend only. One includes agency fees. One divides by leads instead of patients. None of them can compare notes, and worse, none of them can make a confident budget decision, because the number underneath the decision isn’t real.

This post fixes the definition first, then the math, then the diagnosis. What patient acquisition cost actually includes, how to calculate it with a worked example, why healthcare CAC runs structurally higher than ecommerce, the six drivers that quietly push it up, and the order of operations for bringing it down.

What is patient acquisition cost?

Patient acquisition cost is the fully loaded cost to acquire a patient: everything you spend to turn a stranger into a first-time patient, divided by the number of new patients you actually acquired in the same period. It’s the healthcare version of CAC, and the “fully loaded” part is where most brands get it wrong.

The number only works if the numerator is honest. If you count ad spend alone, you’re calculating a media metric, not a business metric, and it will flatter you right up until the P&L disagrees.

What belongs in the numerator

For a telehealth brand, clinic, or supplement DTC company, the acquisition numerator should include:

• Ad spend, across every paid channel, including testing budget on channels that didn’t work.
• Agency and freelancer fees tied to acquisition: media buying, creative production, landing page work.
• Tooling: landing page software, tracking and attribution stack, call tracking, CRM seats used by the acquisition team.
• Sales and intake labor: the loaded cost of the people who answer inquiries, run eligibility checks, chase incomplete intakes, and book consults. For clinics this is front desk time on new-patient calls. For telehealth it’s the intake and support team. This line is routinely the largest omission, and for consult-heavy verticals it can rival the media budget.

What stays out: cost of care delivery, fulfillment, and anything spent serving patients you already have. Those belong in your margin math, not your acquisition math.

How do you calculate patient acquisition cost?

The formula is simple: total acquisition spend in a period, divided by new patients acquired in that period.

Patient acquisition cost = (ad spend + agency and tooling + sales and intake labor) ÷ new patients

Here’s a worked example with deliberately round, illustrative numbers, not benchmarks. Say a telehealth brand’s month looks like this:

• Ad spend: $40,000
• Agency fee: $6,000
• Tooling: $2,000
• Intake and sales labor: $12,000
• Total acquisition spend: $60,000
• New patients: 300

That’s $60,000 ÷ 300, or a $200 patient acquisition cost. Notice that the ad-spend-only version of this number is $133. Both numbers are “CAC” in someone’s dashboard, and one of them is a third lower than reality. When a founder tells us their healthcare CAC “suddenly jumped,” half the time nothing changed except which costs got counted that month.

Two hygiene rules. Divide by patients, not leads: a booked consult that no-shows is not an acquired patient. And match the period: if your consideration cycle runs weeks, spend in March partially converts in April, so measure over a window long enough to absorb the lag or by acquisition cohort.

If you’d rather not run this by hand, our CAC calculator does the fully loaded version for you.

Blended CAC vs. paid CAC vs. new-patient CAC

Three versions of the number, three different jobs. Brands get into trouble by using one where another belongs.

• Paid CAC: paid media spend divided by patients attributed to paid. This is your media efficiency metric. Use it to judge channels and creative, never to judge the business.
• Blended CAC: all acquisition spend divided by all new patients, including organic, referral, and SEO-sourced ones. This is the business metric. A brand with a real referral engine can have an ugly paid CAC and a healthy blended CAC, and it’s the blended number that decides whether the model works.
• New-patient CAC: strips returning and reactivated patients out of the denominator. Critical for clinics and supplement brands, where a “conversion” in the ad platform is often a patient you already paid to acquire two years ago. Counting reactivations as acquisitions makes CAC look better every year your patient base grows, which is exactly when the flattery is most dangerous.

Report all three. If your agency reports only platform CAC, you’re seeing the ad account, not the business.

One more distinction that trips up healthcare teams: cost per lead is not cost per patient. An inquiry, a form fill, or a booked consult is a lead; the patient acquisition cost only exists once someone completes intake and shows up. The multiplier between the two is your inquiry-to-booked-appointment conversion rate, and it’s why two practices in the same specialty with identical ad performance can have wildly different acquisition costs: the one whose front desk answers in minutes and whose intake flow doesn’t leak converts more of the same inquiries into actual patients.

Why is healthcare CAC higher than ecommerce CAC?

Patient acquisition cost in healthcare runs structurally higher than ecommerce CAC for the same media dollars, and it isn’t because health marketers are worse at their jobs. Four forces stack:

• Compliance constraints on targeting and creative. Ad platforms restrict health advertisers from using the personal-attribute targeting, before-and-after imagery, and aggressive claim structures that ecommerce brands lean on freely. You’re running the same auction with fewer weapons, so the winning creative angles are harder to find and burn out faster. (When ads start getting rejected outright, that’s its own compounding tax on CAC.)
• Certification gatekeeping. Prescription-adjacent categories need LegitScript certification before Google and Meta will let the highest-intent inventory serve at all. Brands that skip it don’t pay more for search traffic, they get none, which forces spend into colder, less efficient channels.
• Intake friction. An ecommerce checkout is 90 seconds. A telehealth funnel adds eligibility screening, medical history forms, ID verification, sometimes a synchronous visit. Every added step sheds motivated clickers you already paid for, and that loss lands directly in CAC.
• Longer consideration. Nobody impulse-buys hormone therapy. Health decisions involve research, comparison, and trust-building, which means more touches per conversion and paid dollars spent on people who convert weeks later, often attributed to nothing.

The practical implication: comparing your healthcare CAC to an ecommerce benchmark is meaningless. Compare it to your vertical, and to your own LTV.

What’s actually driving your patient acquisition cost up?

When CAC climbs, the ad account gets blamed first and is usually the last place the problem lives. Across health accounts, the real drivers are almost always some mix of these six:

1. A weak landing and intake funnel. The most common one. Traffic is fine, creative is fine, and the funnel sheds motivated patients between click and completed intake, which multiplies the effective cost of every visitor. We broke down where telehealth funnels leak and how to fix them in the landing page conversion guide.
2. Creative fatigue. Health brands with a small pool of compliant-approved ads run them until performance decays, and because compliance review makes new creative slow to ship, the refresh cycle can’t keep up with the burn rate. Rising CPMs at flat frequency is the early warning.
3. Attribution blindness and double counting. Meta claims the patient, Google claims the same patient, and your “CAC by channel” quietly understates both. Budget then flows to whichever platform lies most confidently. Post-privacy, last-click reporting misses delayed and cross-device conversions too, so real winners look weak and get cut.
4. Channel mix that doesn’t match the category. Pushing all spend into one channel because it “works” ignores that demand capture caps out and demand creation needs a feeder. When the mix is wrong, marginal CAC rises even while average CAC still looks acceptable.
5. Targeting restrictions post-privacy. Signal loss plus health-category targeting limits mean platforms optimize on thinner data for health advertisers than for anyone else. The brands that adapted made creative do the targeting; the brands that didn’t are paying the difference in CAC.
6. Retention ignored, so allowable CAC stays low. This one is sneaky because it doesn’t raise CAC at all, it lowers the ceiling you can afford. If patients churn early, you’re forced to compete in the auction with a small allowable CAC while competitors with strong retention outbid you on the same audiences, profitably.

Diagnose in that order before touching bids or budgets. Five of the six aren’t fixable inside the ad platform.

What does a good patient acquisition cost look like?

There is no universal good number, and anyone quoting one without asking about your vertical, price point, and retention curve is guessing. A good patient acquisition cost is defined by two relationships:

• CAC relative to LTV. The classic yardstick is a healthy multiple of patient lifetime value over CAC. A $300 cost to acquire a patient is excellent for a program that retains patients for many months at a meaningful subscription price, and fatal for a one-off $89 visit. Run your own ratio in the LTV:CAC calculator.
• CAC relative to contribution margin. LTV multiples can hide a cash problem. What matters operationally is how quickly contribution margin, revenue minus the variable cost of serving the patient, pays back the acquisition cost. A brand that recovers CAC inside a month or two can scale aggressively out of cash flow; a brand with a long payback needs financing to grow, even with an identical LTV:CAC ratio.

For actual dollar ranges by vertical and channel, use real category data rather than a universal target: we publish what health brands are paying per patient, by vertical, in our telehealth CAC benchmarks.

How do you lower patient acquisition cost?

In this order. The sequence matters because each step multiplies the next.

1. Fix the funnel first. Intake friction is the cheapest CAC win in healthcare: every point of intake completion you recover is pure CAC reduction with zero media change, and it makes every future ad dollar work harder.
2. Then creative volume. Build a system that ships compliant variants continuously across proven angle categories, clinician authority, patient story, mechanism education, price transparency, so fatigue never gets ahead of the refresh cycle. In a restricted-targeting category, creative is the targeting.
3. Then channel truth. Server-side tracking plus a simple post-purchase survey exposes where platform attribution has been double counting, and lets you rebalance budget against blended CAC by cohort instead of platform-reported ROAS.
4. Then retention, to raise the ceiling. Email and SMS retention work doesn’t lower CAC, it raises the CAC you can afford, which is how brands outbid competitors profitably on the same audiences. We covered the retention side of the equation in the retention and LTV playbook.

Do these in reverse order and you get the usual failure mode: scaling spend into a leaky funnel on misattributed data, which is just buying the same expensive patients twice.

If you want a second set of eyes on your acquisition math, that’s what the free audit on our 30-minute strategy call covers: your fully loaded CAC rebuilt honestly, the drivers ranked, and a written plan whether we work together or not.